measuregroup/AID191652

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID136933127_AID191652_PMID3612688_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103204793_AID191652_PMID3612688_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103203834_AID191652_PMID3612688_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103204307_AID191652_PMID3612688_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103469419_AID191652_PMID3612688_VALUE4
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2367 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15207
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Antiandrogenic activity as weight of prostate after subcutaneous administration at 16 mg/day dose
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103469419 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103203834 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103204307 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136933127 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103204793
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID191652

Total number of triples: 16.